Company profile
Milestone Scientific Inc.
AMEX: MLSS · Healthcare · Medical - Instruments & Supplies
#648 of 1,418 Healthcare companies by revenue47th-percentile growth
EA Score
41DFH 37DQ 38GM 49SS 60
v0.1 · 65/100 weight · provisional
↑ listing tenure, growth stability · ↓ return on equity, Piotroski F
Methodology →Revenue TTM
$8.9M
Rev growth YoY (TTM)
+3.4%
Net income (FY)
-$5.7M
Employees
15
as of 2026-08-20
Market cap
$41.6M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$9.0M$9.0M2025
Net income-$5.7M-$5.7M2025
Operating income-$5.7M-$5.7M2025
Total assets$7.8M$7.8M2025
Liabilities$5.0M$5.0M2025
Equity$2.8M$2.8M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Milestone Scientific Inc.’s revenue?
Milestone Scientific Inc. booked $9.0M in FY2025 revenue, growing 4.0% year over year — about the middle of the pack among Healthcare companies we track, at a -63.8% net margin.
Peers · Healthcare
CareView Communications, Inc.52DBioAge Labs Inc.51DInspireMD, Inc.60CHerbal Dispatch Inc.52DMJardin Group, Inc.——Aspyra Inc.——Neighbors
Essex →Key facts
CEOEric C. Hines
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersRoseland, NJ
ExchangeAMEX: MLSS
Employees15
IPO date1995-11-03
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.